Zobrazeno 1 - 10
of 32
pro vyhledávání: '"K D, Mullen"'
Autor:
K. D. Mullen, Mohamad A. Hussein, A. Koo, T. Mullick, K. Ramasubbu, J. M. Henderson, Robin K. Avery
Publikováno v:
Transplant Infectious Disease. 5:98-103
Background. Thrombotic microangiopathy (TMA) is a rare but potentially lethal complication encountered in solid organ and bone marrow transplant recipients, requiring rapid recognition, diagnosis, and initiation of therapy. Several potential causes h
Autor:
A, Sanyal, Z M, Younossi, N M, Bass, K D, Mullen, F, Poordad, R S, Brown, R P, Vemuru, M, Mazen Jamal, S, Huang, K, Merchant, E, Bortey, W P, Forbes
Publikováno v:
Alimentary pharmacologytherapeutics. 34(8)
Hepatic encephalopathy (HE) is a brain disorder that often results from cirrhosis due to viral hepatitis, metabolic and alcohol-related liver disease, and is characterised by cognitive, psychiatric and motor impairments. Recurrent bouts of overt HE n
Autor:
J S, Bajaj, J, Cordoba, K D, Mullen, P, Amodio, D L, Shawcross, R F, Butterworth, M Y, Morgan
Publikováno v:
Alimentary pharmacologytherapeutics. 33(7)
The clinical classification of hepatic encephalopathy is largely subjective, which has led to difficulties in designing trials in this field.To review the current classification of hepatic encephalopathy and to develop consensus guidelines on the des
Autor:
K. D. Mullen
Publikováno v:
Hepatic Encephalopathy and Nitrogen Metabolism ISBN: 9781402044557
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a96c6dd8d0e2baf443b72bfe5d97c3e
https://doi.org/10.1007/1-4020-4456-9_40
https://doi.org/10.1007/1-4020-4456-9_40
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation Society. 5(2)
Thrombotic microangiopathy (TMA) is a rare but potentially lethal complication encountered in solid organ and bone marrow transplant recipients, requiring rapid recognition, diagnosis, and initiation of therapy. Several potential causes have been ide
Autor:
L, Kramer, A, Gendo, C, Madl, K D, Mullen, K, Kaminski-Russ, G, Sunder-Plassmann, A, Schaffer, E, Bauer, E, Roth, P, Ferenci
Publikováno v:
The International journal of artificial organs. 24(7)
To investigate the role of extracorporeal detoxification in cirrhotic patients with advanced hepatic encephalopathy not responding to medical treatment, 20 patients were randomized to receive six hours of additional sorbent dialysis or ongoing standa
Autor:
E B, Keeffe, G M, Dusheiko, S P, James, K D, Mullen, G T, Everson, N R, Pimstone, J, Donovan, D, Albert
Publikováno v:
Cytokines, cellularmolecular therapy. 5(4)
Hepatitis C virus (HCV) genotyping has been shown to predict response to interferon, but is expensive. HCV serotyping is less expensive and simpler, and may be similarly useful. Using data from a large, randomized trial comparing consensus interferon
Publikováno v:
Hepatology (Baltimore, Md.). 30(2)
Patients with chronic hepatitis C who have not had a sustained hepatitis C virus (HCV)-RNA response or serum alanine transaminase (ALT) response to a 6-month course of interferon (IFN) may respond to higher dose retreatment with consensus interferon
Autor:
W M, Lee, K R, Reddy, M J, Tong, M, Black, D J, van Leeuwen, F B, Hollinger, K D, Mullen, N, Pimstone, D, Albert, S, Gardner
Publikováno v:
Hepatology (Baltimore, Md.). 28(5)
In previous studies employing interferons (IFNs) in the treatment of chronic hepatitis C, there have been few reliable predictors of sustained responses. We retrospectively evaluated the predictive value of hepatitis C virus (HCV)-RNA measurements in
Autor:
K D, Mullen, R, Gacad
Publikováno v:
The Gastroenterologist. 4(3)
The syndrome of hepatic encephalopathy has mystified physicians since the time of Hippocrates, and it continues to do so. It is difficult to succinctly define, diagnose with certainty, or attempt to explore its pathogenesis. The literature on this to